3265 (HRAS)	338,115,384,132
4312 (MMP1)	773,550,819,567
4313 (MMP2)	773,550,819,567
4318 (MMP9)	773,550,819,567
1890 (TYMP)	464,596,510,613
7422 (VEGFA)	773,497,819,514
3576 (CXCL8)	773,602,819,619
7057 (THBS1)	920,451,966,468
1956 (EGFR)	232,497,278,514
999 (CDH1)	232,566,278,583
2064 (ERBB2)	232,519,278,536
1029 (CDKN2A)	652,294,698,311
1026 (CDKN1A)	890,327,936,344
4609 (MYC)	802,146,848,163
11186 (RASSF1)	368,197,414,214
1612 (DAPK1)	532,196,578,213
1613 (DAPK3)	532,196,578,213
23604 (DAPK2)	532,196,578,213
4193 (MDM2)	730,294,776,311
7157 (TP53)	773,327,819,344
1869 (E2F1)	999,417,1045,434
1870 (E2F2)	999,417,1045,434
1871 (E2F3)	999,417,1045,434
5925 (RB1)	999,380,1045,397
2261 (FGFR3)	232,147,278,164
1019 (CDK4)	916,387,962,404
595 (CCND1)	916,370,962,387
9252 (RPS6KA5)	674,147,720,164
1029 (CDKN2A)	970,327,1016,344
1950 (EGF)	159,507,205,524
5594 (MAPK1)	561,146,607,163
5595 (MAPK3)	561,146,607,163
5604 (MAP2K1)	486,146,532,163
5605 (MAP2K2)	486,146,532,163
369 (ARAF)	413,146,459,163
5894 (RAF1)	413,146,459,163
673 (BRAF)	413,146,459,163
3265 (HRAS)	339,146,385,163
3845 (KRAS)	339,146,385,163
4893 (NRAS)	339,146,385,163
4313 (MMP2)	232,452,278,469
4318 (MMP9)	232,452,278,469
7380 (UPK3A)	232,407,278,424
1839 (HBEGF)	159,475,207,492
6714 (SRC)	316,430,364,447
hsa04520: Adherens junction	304,602,406,636
hsa04370: VEGF signaling pathway	743,446,845,480
hsa04012: ErbB signaling pathway	415,489,517,523
hsa04115: p53 signaling pathway	743,361,845,395
hsa04010: MAPK signaling pathway	458,88,560,122
hsa05219: Bladder cancer	40,45,193,70
hsa04110: Cell cycle	1072,361,1174,395
